<html><head>
<meta http-equiv="Content-Type" content="text/html; charset=utf-8">
  </head>
  <body>
    <p>Since John is taking the lead on the new version, my suggestion
      is to let him do it the way that will be most efficient for him. I
      think everyone, including John, have noted your concerns.<br>
    </p>
    <div class="moz-signature">
      <div style="line-height:16px; margin:6px 0; padding:8px 8px 8px
        8px; border-top:1px #aeb1a6 dotted; border-bottom:1px #aeb1a6
        dotted; font-face: Calibri, Verdana; font-size:11px;
        color:grey;">
        <font ;="" font-style="bold" size="2.5px;" color="#0049FF">Tomas
          Helikar, Ph.D.</font> <br>
        Susan J. Rosowski Associate Professor <br>
        Department of Biochemistry | University of Nebraska-Lincoln <br>
        m: <a href="callto:402-547-8904" style="color:rgb(0, 136, 204)
          !important;">402-547-8904</a> | o: <a href="callto:402-472-3530" style="color:rgb(0, 136, 204)
          !important;">402-472-3530</a><br>
        <a href="http://www.postbox-inc.com" style="color:rgb(0, 136,
          204) !important; text-decoration:none !important;
          border-bottom:1px dotted #AAA;">www.helikarlab.org</a> | <a href="http://helikarlab.org" style="color:rgb(0, 136, 204)
          !important; text-decoration:none !important; border-bottom:1px
          dotted #AAA;">cellcollective.org</a><br>
        twitter: <a href="http://twitter.com/helikarlab" style="color:rgb(0, 136, 204) !important; text-decoration:none
          !important; border-bottom:1px dotted #AAA;">@helikarlab</a>, <a href="http://twitter.com/biocollective" style="color:rgb(0,
          136, 204) !important; text-decoration:none !important;
          border-bottom:1px dotted #AAA;">@biocollective</a>
      </div>
    </div>
    <div class="moz-cite-prefix">On 5/18/21 9:27 AM, Jacob Barhak wrote:<br>
    </div>
    <blockquote type="cite" cite="mid:CAM_y+3Tysce7W_zKOFb__KeKT2tBb38U5a2irJEMRjRB_+BF3g@mail.gmail.com">
      
      <div>
        <font face="sans-serif" color="#FF6347">Non-NU Email</font>
        <hr>
      </div>
      <div dir="ltr">So Tomas,
        <div><br>
        </div>
        <div>Before starting editing, to save time it is important that
          we establish what is going to be edited - I voiced my concern
          over the large deletions in Johns version more than once -
          there is a real problem there - many authors may be completely
          eliminated in the name of style - I don't like it - so John
          has to decide how he spends his time - first just define what
          sections you want to contribute in - this will help John
          comprehend the magnitude of the task - he promised editorial
          services for two weeks - so before we start wasting time with
          edits, lets see the entire picture. </div>
        <div><br>
        </div>
        <div>Tomas, what you like may be something I dislike or
          something I do not care about, and eventually we all have to
          agree - and there are about 20 of us - this is a legal
          requirement for copyright transfer. The task here is time
          consuming and I do not envy John and it is important we all
          help him realize the task before he spends time on it.</div>
        <div><br>
        </div>
        <div>And please reply to all - there are some contributors that
          are listed in only one list and some that may not have signed
          up - they all need to be aware of what we are doing. </div>
        <div><br>
        </div>
        <div>Hopefully you identified the sections you want to
          contribute to - please state those to move this forward
          quicker.</div>
        <div><br>
        </div>
        <div>            Jacob</div>
        <div><br>
        </div>
        <div><br>
        </div>
      </div>
      <br>
      <div class="gmail_quote">
        <div dir="ltr" class="gmail_attr">On Tue, May 18, 2021 at 9:08
          AM Tomas Helikar <<a href="mailto:thelikar2@unl.edu" moz-do-not-send="true">thelikar2@unl.edu</a>> wrote:<br>
        </div>
        <blockquote class="gmail_quote" style="margin:0px 0px 0px
          0.8ex;border-left:1px solid rgb(204,204,204);padding-left:1ex">
          <div>
            <p>I suggest we use John's version - the flow has begun to
              improve there and he'll be bringing the content over from
              the submitted version.</p>
            <p>At the top of each of the other version, there should be
              big red "DO NOT EDIT THIS VERSION" and a link to John's
              version that will be the running draft where our efforts
              should focus.</p>
            <p>Best,<br>
            </p>
            <div>
              <div style="line-height:16px;margin:6px
                0px;padding:8px;border-top:1px dotted
                rgb(174,177,166);border-bottom:1px dotted
                rgb(174,177,166);font-size:11px;color:grey"> <font size="2.5px;" color="#0049FF">Tomas Helikar, Ph.D.</font>
                <br>
                Susan J. Rosowski Associate Professor <br>
                Department of Biochemistry | University of
                Nebraska-Lincoln <br>
                m: <a href="callto:402-547-8904" style="color:rgb(0,136,204)" target="_blank" moz-do-not-send="true">402-547-8904</a> | o: <a href="callto:402-472-3530" style="color:rgb(0,136,204)" target="_blank" moz-do-not-send="true">402-472-3530</a><br>
                <a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__www.postbox-2Dinc.com&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=8pX0Br54uLoNQ-PxHY_Nt9ks6sIqSjFiajTJf6yTLYE&s=hJenfL7Oc5LHMtfzjwCDD7iz11gFb7qHTa9Hbu2i1Lk&e=" style="border-bottom:1px dotted
                  rgb(170,170,170);color:rgb(0,136,204);text-decoration:none" target="_blank" moz-do-not-send="true">www.helikarlab.org</a>
                | <a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__helikarlab.org&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=8pX0Br54uLoNQ-PxHY_Nt9ks6sIqSjFiajTJf6yTLYE&s=sM2xjtRiGe7zBH5cWvHqEuH6DqVSiUxQjrE9DZ6JJVI&e=" style="border-bottom:1px dotted
                  rgb(170,170,170);color:rgb(0,136,204);text-decoration:none" target="_blank" moz-do-not-send="true">cellcollective.org</a><br>
                twitter: <a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__twitter.com_helikarlab&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=8pX0Br54uLoNQ-PxHY_Nt9ks6sIqSjFiajTJf6yTLYE&s=bdp23tv-IbXxRa2YpzF18AkQutpCxDtfC7-siSRd5io&e=" style="border-bottom:1px dotted
                  rgb(170,170,170);color:rgb(0,136,204);text-decoration:none" target="_blank" moz-do-not-send="true">@helikarlab</a>,
                <a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__twitter.com_biocollective&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=8pX0Br54uLoNQ-PxHY_Nt9ks6sIqSjFiajTJf6yTLYE&s=WcTsfij98jsXskRk-5qag6ax8_-PZrtIZ5o5R_QV-VQ&e=" style="border-bottom:1px dotted
                  rgb(170,170,170);color:rgb(0,136,204);text-decoration:none" target="_blank" moz-do-not-send="true">@biocollective</a>
              </div>
            </div>
            <div>On 5/18/21 9:05 AM, Jacob Barhak wrote:<br>
            </div>
            <blockquote type="cite">
              <div> <font face="sans-serif" color="#FF6347">Non-NU
                  Email</font>
                <hr> </div>
              <div dir="ltr">Yes Sheriff,
                <div><br>
                </div>
                <div>You have a good point. Here are the versions of
                  the paper that I recall. 
                  <div><br>
                  </div>
                  <div>1. The version we all approved - I suggest we use
                    this: <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__docs.google.com_document_d_1IMEgmdNkx-2DEsnOjGuegpenSIMmKIkK00Lc8Gred3QxM_edit-3Fusp-3Dsharing&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=YDnTfj5kBWpXRZrktQP7smDeXePfRkoZxmwhpBzEh8c&s=FanQUPp95Lqx2G9Ojb6SLVQzkZS6mrqBIt_W-zgW8_Q&e=" target="_blank" moz-do-not-send="true">https://docs.google.com/document/d/1IMEgmdNkx-EsnOjGuegpenSIMmKIkK00Lc8Gred3QxM/edit?usp=sharing</a></div>
                  <div>2. John Gennari version: <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__docs.google.com_document_d_1VvyP3YZQdQYjj8DFKOpQ4pn-5F0pdDGgiT_edit-3Fts-3D60a294c2&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=YDnTfj5kBWpXRZrktQP7smDeXePfRkoZxmwhpBzEh8c&s=7h_7qlaNYzcnYViiFjrrVhBADdtnSQ8eh_Wg_vxmY4I&e=" target="_blank" moz-do-not-send="true">https://docs.google.com/document/d/1VvyP3YZQdQYjj8DFKOpQ4pn_0pdDGgiT/edit?ts=60a294c2</a></div>
                  <div>3. Rahuman Sheriff version: <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__docs.google.com_document_d_1Ag4ipuybjtthxgV0YjXqYP7AwwNSYcWh_edit&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=YDnTfj5kBWpXRZrktQP7smDeXePfRkoZxmwhpBzEh8c&s=yaBZO6lyEXDKmMXfrDPDqy10sDgl0FQgkFFMO3_iShg&e=" target="_blank" moz-do-not-send="true">https://docs.google.com/document/d/1Ag4ipuybjtthxgV0YjXqYP7AwwNSYcWh/edit</a></div>
                  <div>4. Alexander Kulesza version <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__drive.google.com_file_d_1U-5FlTHrV6STXWNT3GiCepvsLk1WdYgzN5_view&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=YDnTfj5kBWpXRZrktQP7smDeXePfRkoZxmwhpBzEh8c&s=6gQoAQCH7F2WOy92A0xjfWmCMUjW7onPku8BYcIsY9Y&e=" target="_blank" moz-do-not-send="true">https://drive.google.com/file/d/1U_lTHrV6STXWNT3GiCepvsLk1WdYgzN5/view</a></div>
                  <div>5. Original Model Reproducibility, Credibility,
                    Standardization subgroup version  <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__docs.google.com_document_d_1cqwXAjBWEiJZ1tUBnf66QVHdHd2fKq-5FW0py7t4PNVLo_edit-3Fusp-3Dsharing&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=YDnTfj5kBWpXRZrktQP7smDeXePfRkoZxmwhpBzEh8c&s=QH6Rgy4why7ib2YGE2T5AA61L68xDE1K-ySoCdKV9ew&e=" target="_blank" moz-do-not-send="true">https://docs.google.com/document/d/1cqwXAjBWEiJZ1tUBnf66QVHdHd2fKq_W0py7t4PNVLo/edit?usp=sharing</a></div>
                  <div>6. Original Integration subgroup  version:  <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__docs.google.com_document_d_1voUSrSpv3AZlC1T-2DBLa3W4wzHQ5vEdJCVrBbwMUTDiQ_edit-3Fusp-3Dsharing&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=YDnTfj5kBWpXRZrktQP7smDeXePfRkoZxmwhpBzEh8c&s=WPFW1D-ECFULPKl8uijQsNA58J5V7TNynIc9OeqCiBE&e=" target="_blank" moz-do-not-send="true">https://docs.google.com/document/d/1voUSrSpv3AZlC1T-BLa3W4wzHQ5vEdJCVrBbwMUTDiQ/edit?usp=sharing</a></div>
                  <div><br>
                  </div>
                  <div>The last two versions hold the original
                    discussions before the merge to the version on top.
                    The history of those contain most contributions -
                    however it will take hours to figure out where each
                    text portion is located in the new version. Yet the
                    new version also includes many modifications. And I
                    believe Hana has another version of proofs that were
                    never made public - we did this revision and proof
                    process before, yet I think she sent me her version
                    privately. I may be mistaken - it was a long time
                    ago. </div>
                  <div><br>
                  </div>
                  <div>Hopefully this list will help understand the
                    undertaking and save time.</div>
                  <div><br>
                  </div>
                  <div>             Jacob</div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                  <div><br>
                  </div>
                </div>
              </div>
              <br>
              <div class="gmail_quote">
                <div dir="ltr" class="gmail_attr">On Tue, May 18, 2021
                  at 8:34 AM Rahuman Sheriff <<a href="mailto:sheriff@ebi.ac.uk" target="_blank" moz-do-not-send="true">sheriff@ebi.ac.uk</a>>
                  wrote:<br>
                </div>
                <blockquote class="gmail_quote" style="margin:0px 0px
                  0px 0.8ex;border-left:1px solid
                  rgb(204,204,204);padding-left:1ex">
                  <div>Dear John G,
                    <div>Many thanks for the update.</div>
                    <div>I like the new ordering :)</div>
                    <div><br>
                    </div>
                    <div>@Jacob, as you mentioned you have 6 versions,
                      could you please add the link to those versions in
                       John G document, so they are all inked.</div>
                    <div>I give consent to to rephrase my contribution
                      or even remove part or all of my contribution to
                      the white paper and present the ideas in other
                      sections if required to make the paper coherent
                      and flow well.</div>
                    <div><br>
                    </div>
                    <div>The white paper has a great collections of
                      ideas, I hope we can get it into a  good shape
                      soon for submission and benefit the scientific
                      community.</div>
                    <div><br>
                    </div>
                    <div>Best regards</div>
                    <div>Sheriff</div>
                    <div><br>
                    </div>
                    <div><br>
                      <blockquote type="cite">
                        <div>On 18 May 2021, at 13:28, James Osborne
                          <<a href="mailto:jmosborne@unimelb.edu.au" target="_blank" moz-do-not-send="true">jmosborne@unimelb.edu.au</a>>
                          wrote:</div>
                        <br>
                        <div>
                          <div dir="ltr">Sorry I wasn't on the call
                            Yesterday (it was 1 am for me so not really
                            achievable). Looking at the emails looks
                            like it was useful. 
                            <div><br>
                            </div>
                            <div>Happy to help how I can, in terms of
                              areas as someone on the multicellular side
                              of life i'm probably most use on 3 but
                              happy to support others.</div>
                            <div><br>
                            </div>
                            <div>James </div>
                          </div>
                          <br>
                          <div class="gmail_quote">
                            <div dir="ltr" class="gmail_attr">On Tue,
                              May 18, 2021 at 3:12 PM John Gennari <<a href="mailto:gennari@uw.edu" target="_blank" moz-do-not-send="true">gennari@uw.edu</a>>
                              wrote:<br>
                            </div>
                            <blockquote class="gmail_quote" style="margin:0px 0px 0px
                              0.8ex;border-left:1px solid
                              rgb(204,204,204);padding-left:1ex">
                              <div>
                                <div>
                                  <div style="font-size:12px;text-align:left;font-family:Helvetica,Arial,sans-serif"><strong>
                                      <table style="width:100%;float:left" cellspacing="0" cellpadding="0" border="0">
                                        <tbody>
                                          <tr>
                                            <td style="color:red"><b>External
                                                email: </b>Please
                                              exercise caution</td>
                                          </tr>
                                        </tbody>
                                      </table>
                                    </strong><br>
                                  </div>
                                  <hr> </div>
                                <p><br>
                                </p>
                                <p>All: About 9 of us had a lively Zoom
                                  meeting today to chat about the
                                  manuscript. By the end, it was a
                                  productive meeting, and I'm hoping
                                  that this email will capture some key
                                  outputs from the meeting. I apologize
                                  if I said some things that were a bit
                                  "inflammatory". Obviously 2 years
                                  would be much too long to get this
                                  paper out-the door. <br>
                                </p>
                                <p>I saw two outcomes. First, we had
                                  some nice ideas and discussion about
                                  re-ordering (initiated by Tomas
                                  Helikar). In the below, I'm going to
                                  propose one possible ordering, but
                                  this is certainly a work-in-progress.
                                  The reason that I think ordering is
                                  important is that it will give us a
                                  much better ability to write a strong
                                  concluding section, where we talk
                                  about themes and the larger arc of our
                                  ideas. <br>
                                </p>
                                <p>Second, we agreed that we should
                                  nominate "point persons" who would be
                                  in charge of at least the initial cut
                                  of each of the subsections. As Jacob
                                  pointed out, this information should
                                  be easy to get from older email and
                                  history of the development of the
                                  paper. During the zoom meeting, we
                                  associated some co-authors with some
                                  sections, but our coverage wasn't
                                  perfect (see challenge #12). Hopefully
                                  people will "stand up" and admit that
                                  some section of text is theirs. <br>
                                </p>
                                <p>So in the below, I include the
                                  original title of the section, a few
                                  words about the content of that
                                  section, and then a name (or several
                                  names) of co-authors who will be the
                                  "point person" to make sure that the
                                  appropriate content is included.
                                  Obviously, all co-authors can and
                                  should chime in on any part of the
                                  text, but the point person should make
                                  sure that the key ideas are included.
                                  <br>
                                </p>
                                <p>The basic ordering idea for the dozen
                                  challenges was to follow the
                                  life-cycle of model development,
                                  execution, sharing and integration,
                                  and eventually implementation. So... <br>
                                </p>
                                <p>*********************************************<br>
                                </p>
                                <p><b>(1) "</b><b>Data</b><b> and
                                    measurement definitions</b>". Before
                                  you can build a model, you must have
                                  data. So data availability and
                                  measurement standards is the place to
                                  start. <br>
                                </p>
                                <p><b>People: </b>Hana D, Jacob B<br>
                                </p>
                                <p><b>(2) "</b><b>The variety of
                                    modeling languages</b>" This is
                                  about the choice of modeling
                                  languages, such as using SBML, CellML,
                                  or Matlab. As I said on the phone
                                  call, this is sort of about
                                  "syntax"--how do you write down your
                                  model? <br>
                                </p>
                                <p><b>People:</b> John G, Jon K, Rahuman
                                  S.</p>
                                <p><b>(3) "</b><b>The variety of
                                    modeling paradigms and scales"</b><b>
                                  </b>Separately from modeling syntax,
                                  we must acknowledge modeling paradigms
                                  with very different semantics. Some
                                  clear examples are PDEs versus ODEs
                                  versus rule-based systems (and
                                  obviously one can combine these).
                                  Certainly semantics might impact
                                  syntax (the prior challenge), in that
                                  certain modeling language might be
                                  appropriate only for some paradigms.</p>
                                <p>People: James G, Eric F (?) <br>
                                </p>
                                <p><b>(4) "</b><b>Units standardization</b>"
                                  A common reason that models are not
                                  reproducible are errors in units, or
                                  misunderstanding about units, or
                                  simply a lack of information about
                                  units. <br>
                                </p>
                                <p>People: Jacob B, Hana D</p>
                                <p><b>(5) "</b><b>A lack of annotations
                                    in models</b>". Once researchers
                                  publish models, they must annotate the
                                  model so that others can understand
                                  it. Quality annotation is essential
                                  for both search and reproducibility. <br>
                                </p>
                                <p>People: John G.</p>
                                <p><b>(6) "</b><b>Models are hard to
                                    locate"</b> If your goal is to
                                  reproduce, understand and possibly
                                  reuse or integrate some other model,
                                  one must first find that model. This
                                  requires annotation (prior section)
                                  and repositories (Physiome Model
                                  Repository, BioModels) and search
                                  platforms (ModeleXchange). <br>
                                </p>
                                <p>People: Jon K, John G.</p>
                                <p><b>(7) "</b><b>Common platforms to
                                    execute models" </b>A model is
                                  pretty worthless as a static object.
                                  For folk to understand and reproduce
                                  models they must be executable. Alas,
                                  there is no single or consistent way
                                  of executing a model -- and of course,
                                  this interacts direction with section
                                  #2 and #3, above: Execution platforms
                                  are usually only for one modeling
                                  paradigm, and often for one modeling
                                  language. The BioSimulators work goes
                                  here.</p>
                                <p>People: Jon K. <br>
                                </p>
                                <p><b>(8) "</b><b>Credibility </b><b>and
                                    validity of models</b>" Once a model
                                  is published, how do folk know it is
                                  right? Model validation is a big topic
                                  and challenge. Credibility follows (in
                                  part) from validation, but also
                                  requires transparency and
                                  reproducibility, etc. <br>
                                </p>
                                <p>People: John Rice, Jon K, Jacob B</p>
                                <p><b>(9) "</b><b>Environments to adapt
                                    and integrate models</b>" As I see
                                  it, one of the end-targets for this
                                  manuscript is to better enable model
                                  integration, to build better models.
                                  There are many challenges with the
                                  task of integrating two (or more)
                                  models. (One that has recently been
                                  discussed is that even if model A and
                                  model B are valid and correct, there
                                  is no guarantee that the combined
                                  model A+B is correct. I liked what
                                  William Waites and Katherine Morse
                                  posted on this subject.) This section
                                  is where SBML-comp and SemGen
                                  environments can be mentioned.</p>
                                <p>People: John G.</p>
                                <p>(<b>10) "Challenges for stochastic
                                    models" </b>Special challenges
                                  specific to stochaistic modeling. An
                                  obvious point to mention is
                                  repeatability -- stochastic models
                                  don't necessarily give the same
                                  results with the same inputs. <br>
                                </p>
                                <p>People: James G., Eric F<br>
                                </p>
                                <p><b>(11) "Licensing barriers" </b>Issues
                                  around "open source" and CC0
                                  licensing. <br>
                                </p>
                                <p>People: Jacob B<br>
                                </p>
                                <p><b>(12) "Barriers to model
                                    implementations and applications"</b> 
                                  (I might suggest this be re-phrased
                                  for better clarity). What this section
                                  should discuss are challenges is
                                  getting a community to actually use
                                  models for "real-world" applications
                                  or decision making. This is more of a
                                  cultural/societal challenge, and thus
                                  seems like a nice big-picture way to
                                  end. <br>
                                </p>
                                <p><b>People: ?? </b>I don't have any
                                  names here...<br>
                                </p>
                                <p>*********************************************</p>
                                <p>We didn't really talk much about it
                                  in the Zoom meeting, but there have
                                  been ideas tossed around about a
                                  "baker's dozen", i.e., adding a 13th
                                  challenge. We could also potentially
                                  merge some of the above. <br>
                                </p>
                                <p class="MsoNormal">The "point persons"
                                  listed above is obviously a subset of
                                  co-authors. That's fine and
                                  appropriate. Just for transparency, I
                                  follow what I think is pretty standard
                                  policy for authorship issues, and
                                  nicely summarized by the<span style="font-family:Helvetica,sans-serif">
                                    International Committee of Medical
                                    Journal Editors (ICMJE); see 2019
                                    updated document at </span><a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__www.icmje.org_icmje-2Drecommendations.pdf&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=YDnTfj5kBWpXRZrktQP7smDeXePfRkoZxmwhpBzEh8c&s=l29d3A9PItAUv4N0WkCuREqes9tSKSW7sk5GDEo6VBA&e=" target="_blank" moz-do-not-send="true">http://www.icmje.org/icmje-recommendations.pdf</a> 
                                  (Or see, below my signature, a summary
                                  of the key points of this document). <br>
                                </p>
                                <p class="MsoNormal">Finally, I've made
                                  the document editable by all at <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__docs.google.com_document_d_1VvyP3YZQdQYjj8DFKOpQ4pn-5F0pdDGgiT_edit-3Fts-3D60a294c2&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=YDnTfj5kBWpXRZrktQP7smDeXePfRkoZxmwhpBzEh8c&s=7h_7qlaNYzcnYViiFjrrVhBADdtnSQ8eh_Wg_vxmY4I&e=" target="_blank" moz-do-not-send="true">
https://docs.google.com/document/d/1VvyP3YZQdQYjj8DFKOpQ4pn_0pdDGgiT/edit?ts=60a294c2</a>
                                  <br>
                                  <span style="font-family:Helvetica,sans-serif"></span></p>
                                <div><br>
                                </div>
                                <p>-John G.<br>
==========================================================================<br>
                                  Associate Professor & Graduate
                                  Program Director      <a href="mailto:gennari@uw.edu" target="_blank" moz-do-not-send="true">
                                    <gennari@uw.edu></a><br>
                                  Dep't of Biomedical Informatics
                                  and                 
                                  telephone:206-616-6641<br>
                                      Medical Education, box
                                  358047                 <br>
                                  University of Washington<br>
                                  Seattle, WA  98109-4714             <a href="https://urldefense.proofpoint.com/v2/url?u=http-3A__faculty.washington.edu_gennari_&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=YDnTfj5kBWpXRZrktQP7smDeXePfRkoZxmwhpBzEh8c&s=7h8T10a2oOTChEmXp5dGxDnAIghmjMroKsXSfcbIH9Y&e=" target="_blank" moz-do-not-send="true">
                                    http://faculty.washington.edu/gennari/</a><br>
==========================================================================<br>
                                  <br>
                                </p>
                                <div><br>
                                </div>
                                <p class="MsoNormal" style="margin-left:0.25in"><span style="font-size:10pt;line-height:107%;font-family:Helvetica,sans-serif">The
                                    ICMJE recommends that authorship be
                                    based on the following 4 criteria: </span></p>
                                <p style="margin-left:0.75in"> <span style="font-size:10pt;line-height:107%;font-family:Helvetica,sans-serif"><span>1.<span>     
                                      </span></span></span><span style="font-size:10pt;line-height:107%;font-family:Helvetica,sans-serif">Substantial
                                    contributions to the conception or
                                    design of the work; or the
                                    acquisition, analysis, or
                                    interpretation of data for the work;
                                    AND</span></p>
                                <p style="margin-left:0.75in"> <span style="font-size:10pt;line-height:107%;font-family:Helvetica,sans-serif"><span>2.<span>     
                                      </span></span></span><span style="font-size:10pt;line-height:107%;font-family:Helvetica,sans-serif">Drafting
                                    the work or revising it critically
                                    for important intellectual content;
                                    AND </span></p>
                                <p style="margin-left:0.75in"> <span style="font-size:10pt;line-height:107%;font-family:Helvetica,sans-serif"><span>3.<span>     
                                      </span></span></span><span style="font-size:10pt;line-height:107%;font-family:Helvetica,sans-serif">Final
                                    approval of the version to be
                                    published; AND </span></p>
                                <p style="margin-left:0.75in"> <span style="font-size:10pt;line-height:107%;font-family:Helvetica,sans-serif"><span>4.<span>     
                                      </span></span></span><span style="font-size:10pt;line-height:107%;font-family:Helvetica,sans-serif">Agreement
                                    to be accountable for all aspects of
                                    the work in ensuring that questions
                                    related to the accuracy or integrity
                                    of any part of the work are
                                    appropriately investigated and
                                    resolved.</span></p>
                                <p style="margin-left:0.75in"> <span style="font-size:10pt;line-height:107%;font-family:Helvetica,sans-serif"><br>
                                  </span></p>
                                <div><br>
                                </div>
                                <p><br>
                                </p>
                              </div>
                            </blockquote>
                          </div>
_______________________________________________<br>
                          Vp-integration-subgroup mailing list<br>
                          <a href="mailto:Vp-integration-subgroup@lists.simtk.org" target="_blank" moz-do-not-send="true">Vp-integration-subgroup@lists.simtk.org</a><br>
                          <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__lists.simtk.org_mailman_listinfo_vp-2Dintegration-2Dsubgroup&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=YDnTfj5kBWpXRZrktQP7smDeXePfRkoZxmwhpBzEh8c&s=T4L8FQANWyunSNQfPEYgCGjRs1jezmcAMA__mVoEmB4&e=" target="_blank" moz-do-not-send="true">https://lists.simtk.org/mailman/listinfo/vp-integration-subgroup</a><br>
                        </div>
                      </blockquote>
                    </div>
                    <br>
                  </div>
                  _______________________________________________<br>
                  Vp-integration-subgroup mailing list<br>
                  <a href="mailto:Vp-integration-subgroup@lists.simtk.org" target="_blank" moz-do-not-send="true">Vp-integration-subgroup@lists.simtk.org</a><br>
                  <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__lists.simtk.org_mailman_listinfo_vp-2Dintegration-2Dsubgroup&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=YDnTfj5kBWpXRZrktQP7smDeXePfRkoZxmwhpBzEh8c&s=T4L8FQANWyunSNQfPEYgCGjRs1jezmcAMA__mVoEmB4&e=" rel="noreferrer" target="_blank" moz-do-not-send="true">https://lists.simtk.org/mailman/listinfo/vp-integration-subgroup</a><br>
                </blockquote>
              </div>
              <br>
              <fieldset></fieldset>
              <pre>_______________________________________________
Vp-integration-subgroup mailing list
<a href="mailto:Vp-integration-subgroup@lists.simtk.org" target="_blank" moz-do-not-send="true">Vp-integration-subgroup@lists.simtk.org</a>
<a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__lists.simtk.org_mailman_listinfo_vp-2Dintegration-2Dsubgroup&d=DwIGaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=YDnTfj5kBWpXRZrktQP7smDeXePfRkoZxmwhpBzEh8c&s=T4L8FQANWyunSNQfPEYgCGjRs1jezmcAMA__mVoEmB4&e=" target="_blank" moz-do-not-send="true">https://urldefense.proofpoint.com/v2/url?u=https-3A__lists.simtk.org_mailman_listinfo_vp-2Dintegration-2Dsubgroup&d=DwIGaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=YDnTfj5kBWpXRZrktQP7smDeXePfRkoZxmwhpBzEh8c&s=T4L8FQANWyunSNQfPEYgCGjRs1jezmcAMA__mVoEmB4&e=</a> 
</pre>
            </blockquote>
          </div>
          _______________________________________________<br>
          Vp-integration-subgroup mailing list<br>
          <a href="mailto:Vp-integration-subgroup@lists.simtk.org" target="_blank" moz-do-not-send="true">Vp-integration-subgroup@lists.simtk.org</a><br>
          <a href="https://urldefense.proofpoint.com/v2/url?u=https-3A__lists.simtk.org_mailman_listinfo_vp-2Dintegration-2Dsubgroup&d=DwMFaQ&c=Cu5g146wZdoqVuKpTNsYHeFX_rg6kWhlkLF8Eft-wwo&r=ct8WBL42ANwALp5sfmoKGqugGgF8k0-4cJjYaO-gSGg&m=8pX0Br54uLoNQ-PxHY_Nt9ks6sIqSjFiajTJf6yTLYE&s=mTrc29J-WAdsLCQmxs01fphssZ6BzffuDQnouLYx7TA&e=" rel="noreferrer" target="_blank" moz-do-not-send="true">https://lists.simtk.org/mailman/listinfo/vp-integration-subgroup</a><br>
        </blockquote>
      </div>
    </blockquote>
  </body>
</html>